Clinical Trials Sponsored by UMN Pharma Inc.
Total 2395 results
-
Astellas Pharma IncCompletedOveractive Bladder | PharmacokineticsFrance
-
Astellas Pharma IncCompletedAny Solid Tumor or LymphomaUnited States, Belgium, United Kingdom
-
Astellas Pharma IncCompletedLiver Transplantation | Hepatitis CItaly, France, Germany, Sweden, United Kingdom, Poland, Spain, Czech Republic
-
Astellas Pharma IncCompletedNon-Alcoholic SteatohepatitisUnited Kingdom, Belgium, Switzerland, Germany, France, Romania, Czech Republic
-
Astellas Pharma IncCompletedPharmacokinetics of AlefaceptUnited States
-
Astellas Pharma IncCompletedOveractive Bladder | Benign Prostatic Hyperplasia | Benign Prostatic HypertrophyJapan
-
Akros Pharma Inc.Completed
-
Akros Pharma Inc.CompletedType II Diabetes MellitusUnited States, Russian Federation, Czech Republic, Hungary, Netherlands
-
ZARS Pharma Inc.Completed
-
Astellas Pharma IncCompleted
-
Astellas Pharma IncCompletedA Study to Investigate the Effect of Food on the Absorption, Distribution and Elimination of ASP1941Healthy | Pharmacokinetics of ASP1941Japan
-
ZARS Pharma Inc.Terminated
-
ZARS Pharma Inc.Completed
-
ZARS Pharma Inc.Completed
-
ZARS Pharma Inc.Completed
-
ZARS Pharma Inc.TerminatedPain | CancerUnited States
-
ZARS Pharma Inc.Completed
-
IASO Pharma Inc.TerminatedCommunity Acquired PneumoniaUnited States
-
Astellas Pharma IncTerminatedComparative Study of Micafungin (FK463) Versus Placebo as Prophylactic Antifungal Therapy in the ICUInvasive Fungal InfectionsUnited States, Canada
-
ZARS Pharma Inc.CompletedHand DermatosesUnited States
-
Astellas Pharma IncCompletedThromboembolismSingapore, Indonesia, Japan, Korea, Republic of, Malaysia, Philippines, Taiwan, Thailand
-
Akros Pharma Inc.Completed
-
Akros Pharma Inc.Terminated
-
Astellas Pharma IncCompletedGastroesophageal RefluxJapan
-
Astellas Pharma IncCompletedCoronary Artery Disease | HypercholesteremiaJapan
-
Astellas Pharma IncCompletedHealthy Subjects | Drug Interactions | Pharmacokinetics of ASP015KUnited States
-
Astellas Pharma IncCompletedHealthy Subjects | Pharmacodynamic and Pharmacokinetic InteractionFrance
-
Astellas Pharma IncCompletedHealthy Volunteers | Pharmacokinetics of Solifenacin SuccinateUnited States
-
Astellas Pharma IncCompletedKidney TransplantationUnited States
-
Astellas Pharma IncCompletedHealthy | Plasma Concentration of YM060Japan
-
Astellas Pharma IncCompletedHealthy Subjects | Pharmacokinetics of ASP015KUnited States
-
Astellas Pharma IncCompletedHealthy Subjects | Pharmacodynamics | Pharmacokinetics of ASP015KUnited States
-
Artisan Pharma, Inc.CompletedSepsis | Disseminated Intravascular CoagulationUnited States, Canada, Thailand, Malaysia
-
Astellas Pharma IncCompleted
-
Astellas Pharma IncCompletedAtrial FibrillationGermany, Korea, Republic of, Australia, Poland, United Kingdom, Japan, South Africa, Russian Federation, Austria, Estonia, Thailand, Bulgaria, France, Spain, Ukraine, India, Israel, Hungary, Slovakia, Malaysia, Philippines, Czech... and more
-
Astellas Pharma IncCompletedVenous ThromboembolismJapan
-
Astellas Pharma IncCompletedUrinary Bladder, OveractiveUnited States
-
Astellas Pharma IncCompletedHealthy | Pharmacokinetics of AtorvastatinJapan
-
Astellas Pharma IncCompletedHealthy | Pharmacokinetics of EnalaprilJapan
-
Astellas Pharma IncCompletedHealthy Volunteer | Pharmacokinetics of YM150Japan
-
Astellas Pharma IncCompleted
-
Astellas Pharma IncCompleted
-
Akela Pharma, Inc.Unknown
-
Quigley Pharma, Inc.CompletedDiabetic NeuropathyUnited States
-
Akros Pharma Inc.Completed
-
Akros Pharma Inc.CompletedType II HyperlipidemiaNetherlands
-
Akros Pharma Inc.Completed
-
Astellas Pharma IncCompletedLiver TransplantationUnited Kingdom, Germany, Spain, Belgium, Switzerland, Canada, Netherlands, Czech Republic, France, Hungary, Austria, Italy
-
Astellas Pharma IncCompletedKeratoconjunctivitis | ConjunctivitisJapan
-
Astellas Pharma IncCompleted